These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16789306)

  • 1. Case study: research subject says institutional review board (IRB) was no help.
    Maloney DM
    Hum Res Rep; 2006 Jan; 21(1):7. PubMed ID: 16789306
    [No Abstract]   [Full Text] [Related]  

  • 2. Case study: agency says institutional review board (IRB) failed to warn subjects of significant problems.
    Maloney DM
    Hum Res Rep; 2006 Mar; 21(3):6-7. PubMed ID: 16789303
    [No Abstract]   [Full Text] [Related]  

  • 3. Research subject complains about how she was treated by an institutional review board (IRB).
    Maloney DM
    Hum Res Rep; 2005 Dec; 20(12):7. PubMed ID: 16607709
    [No Abstract]   [Full Text] [Related]  

  • 4. Case study: research subject says institutional review board (IRB) would not answer her questions.
    Maloney DM
    Hum Res Rep; 2006 Feb; 21(2):7. PubMed ID: 16789309
    [No Abstract]   [Full Text] [Related]  

  • 5. Case study: institutional review board (IRB) did not know about subject problem until after study.
    Maloney DM
    Hum Res Rep; 2006 May; 21(5):6-7. PubMed ID: 16832916
    [No Abstract]   [Full Text] [Related]  

  • 6. Case study: agency says institutional review board (IRB) did not fulfill duties so agency investigation expands.
    Maloney DM
    Hum Res Rep; 2006 Apr; 21(4):6-7. PubMed ID: 16832919
    [No Abstract]   [Full Text] [Related]  

  • 7. Institutional Review Board (IRB) is accused of serious non-compliance.
    Maloney DM
    Hum Res Rep; 2004 Jan; 19(1):8. PubMed ID: 14997903
    [No Abstract]   [Full Text] [Related]  

  • 8. Continued concern: human subject protection, the institutional review board, and continuing review.
    Hoffman S
    Tenn Law Rev; 2001; 68(4):725-70. PubMed ID: 16189912
    [No Abstract]   [Full Text] [Related]  

  • 9. Research administrator should not serve on institutional review board.
    Maloney DM
    Hum Res Rep; 2002 Apr; 17(4):6-7. PubMed ID: 12374181
    [No Abstract]   [Full Text] [Related]  

  • 10. State payer mandates to cover care in US oncology trials: do science and ethics matter?
    Taylor PL
    J Natl Cancer Inst; 2010 Mar; 102(6):376-90. PubMed ID: 20197514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.
    Bramstedt KA; Kassimatis K
    Clin Invest Med; 2004 Dec; 27(6):316-23. PubMed ID: 15675112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concept paper: a virtual centralized IRB system.
    McWilliams R; Hebden CW; Gilpin AM
    Account Res; 2006; 13(1):25-45. PubMed ID: 16770858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Offering results to research subjects: U.S. Institutional Review Board policy.
    Kozanczyn C; Collins K; Fernandez CV
    Account Res; 2007; 14(4):255-67. PubMed ID: 18246944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When a research subject calls with a complaint, what will the institutional review board do?
    Motil KJ; Allen J; Taylor A
    IRB; 2004; 26(1):9-13. PubMed ID: 15281212
    [No Abstract]   [Full Text] [Related]  

  • 15. Untapped potential: IRB guidance for the ethical research use of stored biological materials.
    Wolf LE; Lo B
    IRB; 2004; 26(4):1-8. PubMed ID: 15449408
    [No Abstract]   [Full Text] [Related]  

  • 16. The purpose, composition, and function of an institutional review board: balancing priorities.
    Enfield KB; Truwit JD
    Respir Care; 2008 Oct; 53(10):1330-6. PubMed ID: 18811996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How institutional review boards (IRBs) can handle adverse event reports.
    Maloney DM
    Hum Res Rep; 2006 Jan; 21(1):1-3. PubMed ID: 16789305
    [No Abstract]   [Full Text] [Related]  

  • 18. Where the innocent bear the consequences: lessons from an institution's IRB crisis.
    Warner RS
    Bull Park Ridge Cent; 2000; (18):11-2. PubMed ID: 15744913
    [No Abstract]   [Full Text] [Related]  

  • 19. Case study: university finally can resume human subjects research again.
    Maloney DM
    Hum Res Rep; 2006 Aug; 21(8):6-7. PubMed ID: 17058815
    [No Abstract]   [Full Text] [Related]  

  • 20. Why wasn't an investigational new drug (IND) application required before appropriate study?
    Maloney DM
    Hum Res Rep; 2004 Mar; 19(3):6-7. PubMed ID: 15139342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.